United Therapeutics has announced that it plans to expand its presence in RTP, and is currently developing a master plan for its campus here.
United Therapeutics currently employs approximately 430 people at its T.W. Alexander Drive location. It purchased an additional 132 acres from GlaxoSmithKline in 2012. That property, adjacent to its existing operations, is an integral part of the company’s master planning efforts.
United Therapeutics is an industry leader that is dedicated to developing life-saving therapies for patients with chronic and life-threatening diseases — and we are excited that RTP remains an important part of the company’s future growth plans. Specific questions about United Therapeutics should be directed to the company’s investor relations lead, Dewey Steadman (DSteadman@unither.com.)